IAM 34

IAM 34

IAM 34

Standardising IP valuations: whether, what and how

Valuing IP is complex, with more
than 50 different methods currently
in use. Given the growing
importance of IP to so many
organisations, perhaps now is the
time to re-think whether global
valuation standards make sense

Patrick Sullivan
Download

Features

Small is beautiful

Cellport Systems has thrived as asmall research-based business in amarket dominated by the big boys.An innovative approach to patentingplays a fundamental role in astrategy that has created severalbillion-dollar revenue streams

The patent transaction market at a crossroads

There has never been a better time to acquire high-quality patents at low prices. Companies and other entities should be taking advantage of this fact

Managing IP in a difficult economic environment

There are proven ways to reduce IPinvestment costs while alsoenhancing the value of rightsportfolios. During an economicdownturn, these come into their own

Measuring and conveying IP value the HP way

Hewlett-Packard has devotedsignificant time and resources toensuring that its IP portfolio isaligned to the company’s overallstrategic goals. An extract from arecently published book* about IPbusiness models explains how

The reputation and intangible asset value crash of 2008

Over the last 12 to 18 months thepercentage of listed companyvalues that can be attributed tointangibles has fallen rapidly, tostand at under 50%. Seriousrebuilding work is needed

Business models, value chains and value propositions

To create maximum value fromintellectual property rights, ownershave to ensure that their IPmanagement and businessstrategies are closely aligned

Columns

CIPO forumExamining re-exams: part two

Inter partes re-examinations at theUSPTO could play a part in reducingpatent values and discouraging R&Dinvestment

IP lawyerNo confusion – less joy for trademark owners

In one of its first considerations ofdilution, the ECJ delivered a judgmentthat makes it a difficult concept fortrademark owners to claim

The intellectual capitalistThe highest form of flattery

The modern-day debate about IP is oftendescribed as polarised and ideological.Unfortunately, this may be too kind.Many views are best described as naïveand manipulative. The discourse oncounterfeiting and piracy is a good casein point

IP investorYours, mine, ours

A new book claims that strong patentholderrights undermine social andbusiness objectives, and waste valuableresources

Management report

How does your licence agreement address timely issues?

Licensing deals are negotiated andlicensing agreements written in realtime. A robust pro forma licenceagreement can save hours oftransaction time at critical points ina deal

The Indian version of the Bayh-Dole Act

A bill that would allow governmentfundedacademic institutions topatent their inventions has receiveda mixed reception. It should result ingreater interaction betweenindustry, academia andgovernment, but some fear it doesnot protect the public interest

Options available when commercialising university IP

By implementing a sound andflexible IP management process,universities can spot thetechnologies most suitable forexploitation and give them a goodstart in life. For those that do so,there are rich rewards to be reaped

The truth about business method patents

Business method patents are stillalive and well in the United States.However, the Federal Circuit’slandmark Bilski decision is areminder that they must meet the“machine-or-transformation” test,like any other process claim.

Insights

Sometimes it’s best to look outside of the IP bubble

A background in IP is not aprerequisite for patent andtrademark office bosses inmost jurisdictions; it should notbe in the United States either

Industry insight

How law firms can get a competitive edge in 2009 and beyond

In today’s economic environment, it isessential for law firms, like most otherbusinesses, to distinguish themselvesfrom their competitors in order tomaintain and grow market share, saysSteve Kriston, director of North Americansales for the Scientific business ofThomson Reuters

Unlock unlimited access to all IAM content